A Survey of Insulin-Dependent Diabetes—Part I: Therapies and Devices
This paper surveys diabetes therapies from telemedicine viewpoint. In type 1 diabetes therapies, the exogenous insulin replacement is generally considered as a primary treatment. However, the complete replacement of exogenous insulin is still a challenging issue because of its complexity of modeling...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2008-01-01
|
| Series: | International Journal of Telemedicine and Applications |
| Online Access: | http://dx.doi.org/10.1155/2008/639019 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832564437203025920 |
|---|---|
| author | Daisuke Takahashi Yang Xiao Fei Hu Michael Lewis |
| author_facet | Daisuke Takahashi Yang Xiao Fei Hu Michael Lewis |
| author_sort | Daisuke Takahashi |
| collection | DOAJ |
| description | This paper surveys diabetes therapies from telemedicine viewpoint. In type 1 diabetes therapies, the exogenous insulin replacement is generally considered as a primary treatment. However, the complete replacement of exogenous insulin is still a challenging issue because of its complexity of modeling the dynamics, which is typically modeled nonlinearly. On the other hand, thanks to the progress of medical devices, currently the diabetes therapies are being automated. These medical devices include automated insulin pumps and blood glucose sensors. Insulin pumps are designed to create artificial insulin perfusion while they largely rely on the blood glucose profile measurements and these measurements are achieved by one or more blood glucose sensors. The blood glucose measurements are also important for the insulin-dependent diabetes therapies. An insulin pump along with sensors establishes a good feedback system providing the appropriate amount of the exogenous insulin on demand. Controlling the amount of exogenous insulin to suppress the blood glucose levels requires complicated computations. This paper mostly explains both type 1 and 2 diabetes and their mechanisms accompanied by descriptions of diabetes therapy and medical devices currently utilized in the therapy. |
| format | Article |
| id | doaj-art-e69a7d64d66647c4b55216c8e19d0860 |
| institution | Kabale University |
| issn | 1687-6415 1687-6423 |
| language | English |
| publishDate | 2008-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | International Journal of Telemedicine and Applications |
| spelling | doaj-art-e69a7d64d66647c4b55216c8e19d08602025-02-03T01:11:02ZengWileyInternational Journal of Telemedicine and Applications1687-64151687-64232008-01-01200810.1155/2008/639019639019A Survey of Insulin-Dependent Diabetes—Part I: Therapies and DevicesDaisuke Takahashi0Yang Xiao1Fei Hu2Michael Lewis3Department of Computer Science, The University of Alabama, Tuscaloosa, AL 35487-0290, USADepartment of Computer Science, The University of Alabama, Tuscaloosa, AL 35487-0290, USADepartment of Computer Engineering, Rochester Institute of Technology, Rochester, NY 14623-5603, USADepartment of Computer Engineering, Rochester Institute of Technology, Rochester, NY 14623-5603, USAThis paper surveys diabetes therapies from telemedicine viewpoint. In type 1 diabetes therapies, the exogenous insulin replacement is generally considered as a primary treatment. However, the complete replacement of exogenous insulin is still a challenging issue because of its complexity of modeling the dynamics, which is typically modeled nonlinearly. On the other hand, thanks to the progress of medical devices, currently the diabetes therapies are being automated. These medical devices include automated insulin pumps and blood glucose sensors. Insulin pumps are designed to create artificial insulin perfusion while they largely rely on the blood glucose profile measurements and these measurements are achieved by one or more blood glucose sensors. The blood glucose measurements are also important for the insulin-dependent diabetes therapies. An insulin pump along with sensors establishes a good feedback system providing the appropriate amount of the exogenous insulin on demand. Controlling the amount of exogenous insulin to suppress the blood glucose levels requires complicated computations. This paper mostly explains both type 1 and 2 diabetes and their mechanisms accompanied by descriptions of diabetes therapy and medical devices currently utilized in the therapy.http://dx.doi.org/10.1155/2008/639019 |
| spellingShingle | Daisuke Takahashi Yang Xiao Fei Hu Michael Lewis A Survey of Insulin-Dependent Diabetes—Part I: Therapies and Devices International Journal of Telemedicine and Applications |
| title | A Survey of Insulin-Dependent Diabetes—Part I: Therapies and Devices |
| title_full | A Survey of Insulin-Dependent Diabetes—Part I: Therapies and Devices |
| title_fullStr | A Survey of Insulin-Dependent Diabetes—Part I: Therapies and Devices |
| title_full_unstemmed | A Survey of Insulin-Dependent Diabetes—Part I: Therapies and Devices |
| title_short | A Survey of Insulin-Dependent Diabetes—Part I: Therapies and Devices |
| title_sort | survey of insulin dependent diabetes part i therapies and devices |
| url | http://dx.doi.org/10.1155/2008/639019 |
| work_keys_str_mv | AT daisuketakahashi asurveyofinsulindependentdiabetespartitherapiesanddevices AT yangxiao asurveyofinsulindependentdiabetespartitherapiesanddevices AT feihu asurveyofinsulindependentdiabetespartitherapiesanddevices AT michaellewis asurveyofinsulindependentdiabetespartitherapiesanddevices AT daisuketakahashi surveyofinsulindependentdiabetespartitherapiesanddevices AT yangxiao surveyofinsulindependentdiabetespartitherapiesanddevices AT feihu surveyofinsulindependentdiabetespartitherapiesanddevices AT michaellewis surveyofinsulindependentdiabetespartitherapiesanddevices |